Even after a series of reforms in 2015, advocates say U.S. policy still discriminates and furthers HIV stigma. Anthony Santella, Dr.P.H., M.P.H., has a better idea.
The attention of this specific U.S. president on HIV is curious. However, while it may be initially disorienting, it makes sense, explains David Wohl, M.D.
In this op-ed, a group of family physicians and HIV specialists revisit the cruel reality happening at the U.S. border for people living with HIV.
A systematic review of research between 2000 and 2016 found no studies of interventions specifically designed to support medication adherence among HIV-positive black women.
Many HIV service organizations need to grow and change, and that means becoming more reflective of the communities they serve, from bottom to top. Here's some advice on how to get there.
When Providers Don't Use Gender-Affirming Language, It Negatively Impacts HIV-Positive Transgender Women's Health
A new study shows that helping clinicians use gender-affirming language is important for transgender women in care. But we need more research on how HIV medications and feminizing hormones interact.
For people taking medications for HIV prevention, HIV treatment, STIs, or transgender health care, this couple -- in life and in business -- seeks to revolutionize the pharmacy experience at TIN Rx in San Francisco.
This population is under-represented in HIV data, and few prevention or treatment interventions exist to support them. A new meta-analysis hopes to paint a picture of what's needed.
Tokenism, a form of racism, is pervasive in the U.S. -- particularly within HIV organizations whose mission is to serve people of color.
"Providers need to not make assumptions about what black and brown and, more generally, trans patients of color need," one study co-author said.